Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Sprangers

Showing results (11-20 of 182) with videos related to

Pageof 19
Sort By:
Transplantation Reviews (Orlando, Fla.)|August 20, 2013
Recurrence of glomerulonephritis after renal transplantationBen Sprangers, Dirk R Kuypers
Clinical Journal of the American Society of Nephrology : CJASN|May 4, 2019
AKI in Patients Receiving Immune Checkpoint InhibitorsMark A Perazella, Ben Sprangers
Advances in Chronic Kidney Disease|July 11, 2022
Cancer Drug Dosing in Chronic Kidney Disease and DialysisAnushree C Shirali, Ben Sprangers
Clinical Kidney Journal|June 1, 2023
Testing the functional reserve of the kidney before hematopoietic stem cell transplantation: doubt remainsBart De Moor, Ben Sprangers
Clinical Kidney Journal|February 10, 2021
Tyrosine kinase inhibitor-induced hypertension-marker of anti-tumour treatment efficacy or cardiovascular risk factor?Anastasia G Ptinopoulou, Ben Sprangers
Clinical Kidney Journal|May 10, 2021
Checkpoint inhibitor therapy-associated acute kidney injury: time to move on to evidence-based recommendationsMark A Perazella, Ben Sprangers
Clinical Kidney Journal|November 2, 2023
Proton pump inhibitors and adverse kidney outcomes during immune checkpoint blockade: time to sound the alarm?Hui Zhuan Tan, Ben Sprangers
Biomed Research International|June 18, 2016
FSGS: Diagnosis and Diagnostic Work-UpBen Sprangers, Björn Meijers, Gerald Appel
Mayo Clinic Proceedings|November 24, 2006
Late referral of patients with chronic kidney disease: no time to wasteBen Sprangers, Pieter Evenepoel, Yves Vanrenterghem
Transplantation|July 16, 2013
suPAR and FSGS: the gap between bench and bedsideMaarten Naesens, Björn Meijers, Ben Sprangers
Pageof 19

Showing results (11-20 of 182) with videos related to

Sort By:
Pageof 19
Transplantation Reviews (Orlando, Fla.)|August 20, 2013
Recurrence of glomerulonephritis after renal transplantationBen Sprangers, Dirk R Kuypers
Clinical Journal of the American Society of Nephrology : CJASN|May 4, 2019
AKI in Patients Receiving Immune Checkpoint InhibitorsMark A Perazella, Ben Sprangers
Advances in Chronic Kidney Disease|July 11, 2022
Cancer Drug Dosing in Chronic Kidney Disease and DialysisAnushree C Shirali, Ben Sprangers
Clinical Kidney Journal|June 1, 2023
Testing the functional reserve of the kidney before hematopoietic stem cell transplantation: doubt remainsBart De Moor, Ben Sprangers
Clinical Kidney Journal|February 10, 2021
Tyrosine kinase inhibitor-induced hypertension-marker of anti-tumour treatment efficacy or cardiovascular risk factor?Anastasia G Ptinopoulou, Ben Sprangers
Clinical Kidney Journal|May 10, 2021
Checkpoint inhibitor therapy-associated acute kidney injury: time to move on to evidence-based recommendationsMark A Perazella, Ben Sprangers
Clinical Kidney Journal|November 2, 2023
Proton pump inhibitors and adverse kidney outcomes during immune checkpoint blockade: time to sound the alarm?Hui Zhuan Tan, Ben Sprangers
Biomed Research International|June 18, 2016
FSGS: Diagnosis and Diagnostic Work-UpBen Sprangers, Björn Meijers, Gerald Appel
Mayo Clinic Proceedings|November 24, 2006
Late referral of patients with chronic kidney disease: no time to wasteBen Sprangers, Pieter Evenepoel, Yves Vanrenterghem
Transplantation|July 16, 2013
suPAR and FSGS: the gap between bench and bedsideMaarten Naesens, Björn Meijers, Ben Sprangers
Pageof 19